Skip to content

Zantac Lawsuit Investigation: Zantac Linked with Certain Types of Cancers

Nov 04, 2020
Shamis & Gentile, P.A.
Food and Drug Administration

You may have noticed recent news articles or commercials regarding Zantac lawsuit investigation actions which have linked Zantac with certain types of cancers. As Zantac lawyers, our law firm at Shamis & Gentile, P.A is dedicated to helping people get the compensation they deserve. If you were a regular user of Zantac that was later diagnosed with cancer, please read the following information for more information about the Zantac lawsuit investigation.

Zantac and Potential Cancer Link

In September of 2019, the FDA announced that they had discovered NDMA (or N-nitrosodimethylamine) present in both the OTC and prescription versions of Zantac, a popular heartburn medication. NDMA is a carcinogenic compound which has been linked to several types of cancer.

This announcement from the FDA came after an independent lab submitted the results of testing to the FDA which indicated extremely elevated levels of NDMA in Zantac and generic ranitidine medications. After the FDA’s statement, some pharmacies pulled Zantac products voluntarily, pending further information. In April of 2020, the FDA announced an immediate recall of all Zantac medications due to the potential for NDMA contamination.

In addition to its association with the development of certain cancers (including liver cancer, kidney cancer, esophageal cancer, and bladder cancer) NDMA is associated with other harmful side-effects. Even short-term exposure to NDMA can lead to liver damage, including liver scarring and fibrosis; whereas long-term exposure can greatly increase the risk for developing tumors, as well as nausea, vomiting, abdominal cramps and pain, reduced liver function, reduced kidney function, reduced lung function and an enlarged liver. Some other side effects associated with Zantac use have included:

  • Low blood platelet levels
  • Nervous system disorders
  • Vitamin B-11 deficiencies
  • Skin rashes
  • Pneumonia risk
  • Hair loss
  • Irregular heartbeat

Since 1986, NDMA has been classified as “extremely hazardous”; due to this classification, extensive testing and reporting of potential NDMA amounts is required in order to mitigate the serious risk that NDMA exposure causes. Some of the current lawsuits filed in relation to Zantac argue that the makers of Zantac were aware of potential NDMA contamination but did not disclose this to the public for fear of losing money.

Zantac Lawsuit Investigation

If you or a loved one took Zantac and were later diagnosed with cancer or other health problems linked to Zantac and NDMA, then you may be entitled to compensation. we want to ensure that everyone impacted by this issue receives the compensation that they deserve. Our Zantac lawsuit lawyers will seek to compensate for:

  • Pain and suffering, both physical and mental
  • Loss of wages in the past and future
  • Loss of earning capacity in the past and future
  • Punitive damages, if applicable
  • Cost of medical bills

Contact Zantac Lawsuit Lawyers Today

Have you been impacted by this Zantac recall? If so, you may be eligible for a lawsuit investigation. You should contact your professional Zantac Lawyers, Shamis & Gentile, P.A. with your information for a free case review. We can be contacted via our email at or contacted via phone at 305-479-2299. Do not hesitate to call today.


Submit a Class Action Claim

Submit a class action claim today; there are no associated fees or expenses unless we manage to win the case on your behalf.